Kodiak Sciences (Nasdaq: KOD) priced an upsized underwritten public offering of 6,956,522 shares of common stock at $23.00 per share, producing expected gross proceeds of approximately $160 million before underwriting discounts, commissions and expenses.
The offering is expected to close on or about December 18, 2025, subject to customary closing conditions. Kodiak granted underwriters a 30-day option to buy up to an additional 1,043,478 shares at the public offering price less underwriting discounts and commissions. All shares are being sold by Kodiak Sciences.
J.P. Morgan, Jefferies, Evercore ISI and UBS Investment Bank are joint book-running managers. The shares are offered under a shelf registration on Form S-3 declared effective June 2, 2023, and prospectus materials have been filed with the SEC.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.